Therapy: SGLT2 inhibitor dapagliflozin promotes glucagon secretion in α islet cells.
Jennifer
J
Sargent
D000818:Animals; D001559:Benzhydryl Compounds / Q000737:chemistry*; D005260:Female; D005786:Gene Expression Regulation; D005934:Glucagon / Q000378:metabolism*; D050416:Glucagon-Secreting Cells / Q000378:metabolism*; D005960:Glucosides / Q000737:chemistry*; D006801:Humans; D008297:Male; D051297:Sodium-Glucose Transporter 2 / Q000378:metabolism*
D001559:Benzhydryl Compounds; D005960:Glucosides; D051297:Sodium-Glucose Transporter 2; D005934:Glucagon